Undifferentiated nasopharyngeal cancer (UCNT): Current diagnostic and therapeutic aspects

This publication has 122 references indexed in Scilit:

• A retrospective analysis of 201 nasopharyngeal carcinoma PTS to compare staging classifications
  European Journal Of Cancer, 1993
• Phase II trial of recombinant interferon gamma in refractory undifferentiated carcinoma of the nasopharynx
  Head & Neck, 1993
• Carcinoma of the nasopharynx: Analysis of treatment results in 167 consecutively admitted patients
  Head & Neck, 1992
• Alternating chemo-radiotherapy with cisplatin and 5-fluorouracil plus bleomycin by continuous infusion for locally advanced undifferentiated carcinoma nasopharyngeal type
  European Journal Of Cancer, 1992
• Detection of anti‐epstein‐barr‐virus transactivator (ZEBRA) antibodies in sera from patients with nasopharyngeal carcinoma
  International Journal of Cancer, 1991
• Acute blindness during treatment of recurrent or metastatic nasopharyngeal carcinoma with doxorubicin and CCNU
  European Journal of Cancer and Clinical Oncology, 1990
• RECURRENT NASOPHARYNGEAL CARCINOMA—TWO LONG TERM DISEASE‐FREE REMISSIONS WITH NON‐CISPLATINUM BASED COMBINATION CHEMOTHERAPY
  Anz Journal of Surgery, 1985
• Effect of Fibroblast-Derived Interferon Administration on Immune Responsiveness in a Patient with Nasopharyngeal Carcinoma
  Journal of Interferon Research, 1983
• SUCCESSFUL TREATMENT OF NASOPHARYNGEAL CARCINOMA WITH INTERFERON
  The Lancet, 1980
• Human Leukocyte Interferon for the Treatment of Herpes Zoster in Patients with Cancer
  New England Journal of Medicine, 1978